Puma Biotechnology

Puma Biotech reports 4Q loss
Yahoo/AP
Thu, 03/2/17 - 09:41 am
Puma Biotechnology
earnings
Roche Has Aphinity For Perjeta Trial Success, But Not Puma
Seeking Alpha
Sun, 01/8/17 - 03:28 pm
Roche
Perjeta
Puma Biotechnology
breast cancer
Puma shares ripped after a new grade 3 diarrhea threat is highlighted in an abstract
Endpoints
Mon, 11/14/16 - 10:41 pm
Puma Biotechnology
neratinib
Puma Bio's Desperate Money Grab Signals Breast Cancer Drug Trouble
TheStreet.com
Thu, 10/20/16 - 03:31 pm
Puma Biotechnology
breast cancer
neratinib
SEC charges former Puma biotech exec with $1.1 million in insider trading
Stat/Pharmalot
Fri, 09/30/16 - 12:34 pm
insider trading
Puma Biotechnology
SEC
Could Puma Biotech Double After This FDA Approval?
24/7 Wall St
Sun, 09/25/16 - 11:42 am
Puma Biotechnology
neratinib
3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions
Motley Fool
Wed, 09/21/16 - 10:59 pm
biotech
FDA
Aerie Pharma
Rhopressa
Flexion
Zilretta
Puma Biotechnology
neratinib
Puma Biotech Rises on Key FDA Approval
24/7 Wall St
Wed, 09/21/16 - 09:34 am
Puma Biotechnology
FDA
neratinib
breast cancer
After Losing Medivation, Who Is Gilead Going After Next?
Forbes
Mon, 09/19/16 - 03:39 pm
Medivation
Gilead Sciences
M&A
Puma Biotechnology
Kite Pharma
Incyte
Portola Pharmaceuticals
3 Hottest Cancer Biotech Acquisition Targets After Medivation
Forbes
Tue, 09/6/16 - 11:11 pm
cancer
biotech
M&A
Puma Biotechnology
Jazz Pharmaceuticals
Kite Pharma
Puma Biotech shares jump on breast cancer study, FDA application
Marketwatch
Thu, 07/21/16 - 09:08 pm
Puma Biotechnology
FDA
breast cancer
neratinib
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
biotech
M&A
Alder Biopharmaceuticals
Biomarin
Coherus Biosciences
Intercept Pharma
Ultragenyx
Seattle Genetics
Adamas Pharmaceuticals
Alexion
Clovis Oncology
Corbus Pharmaceuticals
Incyte
Prothena
Puma Biotechnology
Tesaro
Versartis
5 Major Clinical Trial Results Coming Up
24/7 Wall St
Wed, 05/25/16 - 09:19 pm
clinical trials
Vertex Pharmaceuticals
Orkambi
Puma Biotechnology
neratinib
GW Pharma
Epidiolex
Agios Pharmaceuticals
AG-348
AG-519
Dermira
DRM-04
Biotech's Top 5 Stock Winners, And Losers, In Q1 2016
Forbes
Thu, 03/31/16 - 09:49 pm
biotech
PTC Therapeutics
Celldex Therapeutics
Biocryst
Puma Biotechnology
Portola Pharmaceuticals
MedicNova
BioTie Therapies
Editas Medicine
AveXis
Inovio
8 Major Biopharma Events Coming Later in 2016 and in 2017
24/7 Wall St
Tue, 03/29/16 - 10:33 pm
Vertex Pharmaceuticals
VX-661
cystic fibrosis
Incyte
ruxolitinib
colorectal cancer
breast cancer
Ultragenyx
KRN23
osteomalacia
GW Pharma
Epidiolex
Puma Biotechnology
neratinib
Celator Pharmaceuticals
Vyxeos
Biocryst
OPuS-2
BCX7353
HAE
Galena Biopharma
NeuVax
trastuzumab
8 Biotech Stocks That Have a ‘Greater Probability’ of Being Acquired
Barron's
Tue, 03/29/16 - 12:24 pm
biotech
M&A
Ardelyx
Ophthotech
Medivation
Puma Biotechnology
Ultragenyx
Portola Pharmaceuticals
Versartis
Relypsa
4 More Key FDA Decisions in March
24/7 Wall St
Wed, 03/16/16 - 07:24 pm
FDA
Bioline Rx
Dynavax Technologies
Puma Biotechnology
Durect
2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
TheStreet.com
Thu, 01/7/16 - 01:02 pm
biotech
Celgene
biosimilars
Isis Pharmaceuticals
CAR-T
Bluebird Bio
Puma Biotechnology
MannKind
4 Top FDA Decisions Expected in Q1
24/7 Wall St
Mon, 01/4/16 - 10:05 am
FDA
Zafgen
beloranib
Biomarin
Peg-Pal
PB272
Puma Biotechnology
Aquinox
AQX-1125
10 Biotechs Short Sellers Are Betting Against
Yahoo/Benzinga
Wed, 12/30/15 - 10:40 am
biotech
Global Blood Therapeutics
Clovis Oncology
Epizyme
Bluebird Bio
Puma Biotechnology
Tokai
MannKind
Myriad Genetics
Orexigan
KaloBios

Pages